MELISSA THOMAS: Open Payments
NPI 1235326588 · TAYLORSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$324 in 18 payments from 9 companies in 2025. Trend: 2023 $657 · 2024 $412 · 2025 $324
Food & beverage: $324
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $80 |
| Novo Nordisk Inc | 5 | $76 |
| PFIZER INC. | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Amgen Inc. | 1 | $24 |
| Ethicon US, LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Ozempic, PREVNAR 20, QULIPTA, UBRELVY, REXULTI, REPATHA, STRATAFIX, MOUNJARO.
Industry payments across KY — which companies pay providers there.
